![EHA Unplugged Ethical Considerations in CAR T-cell Therapy with Marie-Jose Kersten](https://oncodaily.com/pub/uploads/2024/08/46ea31038dfc4dfd9dc3a73e60b83b41-e1722531735543.jpg)
EHA Unplugged Ethical Considerations in CAR T-cell Therapy with Marie-Jose Kersten
EHA (European Hematology Association) shared a post on X:
”New CART podcast out!
Join Professor Marie-Jose Kersten to explore ethical and practical challenges in CAR T. Dive into the intricacies of patient access, ethical considerations and financial implications.
Listen on podcast platforms, YouTube and EHA Campus.”
Source: EHA/X
Marie Jose Kersten is a professor of hematology at Amsterdam University Medical Centers. She is the chair of the EHA (European Hematology Association) Scientific Working Group Lymphoma. She is also co-founder and chair of the Board of the HOVON/Lunenburg Lymphoma Phase I/II Consortium (HOVON/LLPC). She is the principal investigator for several phase I/II clinical trials focusing on the biology and treatment of NHL, Waldenstrom’s macroglobulinemia and Hodgkin lymphoma.